Breast cancer survivors need a comprehensive care plan, says doctor
Survivor care for cancer patients should address physical and psychological symptoms through an integrated model, expert says.
PARP inhibitors and breast cancer: Questions remain about wider use
Oncologists are still trying to understand the best drug targets and the value of combo treatments.
Genomic assay changes minds on HER2+ BC treatment
In a small study, 56% of oncologists revised plans after getting results of HER2DX tests.
Atezolizumab is associated with enhanced response in triple-negative breast cancer
The addition of atezolizumab to chemotherapy yielded higher pCR than chemotherapy alone.
Risk for breast cancer reduced after bariatric surgery
“The importance of this study is that it shows that weight loss in midlife can reduce breast cancer risk back to or even below the risk of similar...
Patritumab deruxtecan shows promise for breast cancer patients
Preliminary studies show acceptable safety profiles and clinical responses that justify future trials.
T-DXd for HER2-low BC: Analysis confirms adverse effects
But T-DXd demonstrates a manageable safety profile consistent with prior reports, says the author of a new paper.
BMI has greater impact on survival in younger breast cancer patients
Study of women on endocrine therapy for breast cancer addresses the effects of BMI on survival.
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
New USPSTF draft suggests mammography start at 40, not 50
“It is now clear that screening every other year starting at age 40 has the potential to save about 20% more lives among all women.”